Penumbra, Inc Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Penumbra, Inc (PEN) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of 0.60% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-02-25
- Penumbra, Inc effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was 0.60%, a 40.00% decline from fiscal 2023.
- Penumbra, Inc effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was 1.00%, a 85.51% decline from fiscal 2022.
- Penumbra, Inc effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was 6.90%.
- Penumbra, Inc effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2021 was -2.70%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | 0.60% 10-K · filed 2026-02-25 | |
| 2023-12-31 | 1.00% 10-K · filed 2026-02-25 | |
| 2022-12-31 | 6.90% 10-K · filed 2025-02-18 | -3.30% 10-K · filed 2023-02-23 |
| 2021-12-31 | -2.70% 10-K · filed 2024-02-22 | -1.20% 10-K · filed 2022-02-22 |
| 2020-12-31 | -1.50% 10-K · filed 2023-02-23 | |
| 2019-12-31 | 2.60% 10-K · filed 2022-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |